Multi-antigen Specific T cells post-Hematopoietic Stem Cell Transplant to Enhance anti-Leukemia and anti-Viral Immunity in vivo


Momentum Fellow (2021-Present)

Hannah Kinoshita, MD, Children's National Hospital

Dr Kinoshita is evaluating the immunobiology of multi-antigen specific T-cell therapy infused to patients to reduce the two most common causes of morbidity and mortality following stem cell transplant—cancer relapse and infection.

BACK TO OUR PORTFOLIO